Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis
- 1 August 2001
- Vol. 130 (2) , 175-181
- https://doi.org/10.1067/msy.2001.115827
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Proteases and Protease Inhibitors in Taurocholate-Induced Acute Pancreatitis in RatsJournal of Gastrointestinal Cancer, 1999
- Frank Brooks Memorial LecturePancreas, 1998
- Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde CholangiopancreatographyNew England Journal of Medicine, 1996
- Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitisThe American Journal of Surgery, 1996
- A Better Model of Acute Pancreatitis for Evaluating TherapyAnnals of Surgery, 1992
- Gabexate Mesilate (FOY) Protects Against Ceruletide-Induced Acute Pancreatitis in the RatPancreas, 1987
- Pharmacological Studies of FUT-175, Nafamostat Mesilate V. Effects on the Pancreatic Enzymes and Experimental Acute Pancreatitis in RatsThe Japanese Journal of Pharmacology, 1986
- New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsinBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitisBritish Journal of Surgery, 1978
- Pharmacokinetic observations following intravenous administration of radioactive labelled aprotinin in volunteersEuropean Journal of Drug Metabolism and Pharmacokinetics, 1978